This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stockpickr's Activist Track Stocks

Icahn also is pushing for Enzon Pharmaceuticals (ENZN - Get Report) to sell itself.

The pharmaceutical company is definitely worth watching. In addition to Icahn's push, DellaCamera Capital sent a letter to Enzon in which the activist hedge fund said it is unhappy with the compensation granted to Enzon Chairman and CEO Jeffrey Buchalter. DellaCamera further called for the resignation of Goran A. Ando, Rolf A. Classon and Victor P. Micati, all members of Enzon's compensation committee.

Next on the list is Circuit City (CC). Dallas-based hedge fund HBK Investments is urging Circuit City to allow due diligence by Blockbuster (BBI), following Blockbuster's acquisition proposal. HBK also urged Circuit City's board to create a competitive bidding process in order to maximize shareholder value.

It is worth pointing out that Circuit City has a 22% short position.

Last on the list is Applied Biosystems Group (ABI). Steven Cohen of SAC Capital sent a letter to Applied Biosystems suggesting a sale of the company. Cohen said that his fund encouraged the company's board to take a number of actions and to explore all strategic alternatives.

For more activist ideas, please check out the Latest Activist Situations, a Stockpickr portfolio that tracks the latest activist situations recorded by the StreetInsider.com 13D Tracker.

You can also check out the latest activist filings from Barron's, a list we update every Saturday.
Stockpickr is a wholly owned subsidiary of TheStreet.com.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ABI $22.98 1.01%
CC $16.00 0.00%
BIIB $403.94 0.00%
ENZN $1.20 0.00%
AAPL $125.42 0.00%

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.11 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs